Delivra Health Brands Inc. carries a market capitalization of 3.13M, placing it among publicly traded companies globally. Its enterprise value stands at 4.29M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.13M |
| Enterprise Value | 4.29M |
Delivra Health Brands Inc. currently has 31.26M shares outstanding.
| Shares Outstanding | 31.26M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Delivra Health Brands Inc. trades at a trailing price-to-earnings ratio of 721.09. The price-to-sales ratio is 0.44, and the price-to-book ratio stands at -0.25.
| PE Ratio | 721.09 |
| PS Ratio | 0.44 |
| PB Ratio | -0.25 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | -10.83 |
| P/OCF Ratio | -10.83 |
| EV / Sales | 0.34 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 18.86 |
Delivra Health Brands Inc. maintains a current ratio of 3.43, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 52.87, indicating elevated leverage, while an interest coverage ratio of -2.68 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.43 |
| Quick Ratio | 2.60 |
| Debt / Equity | 52.87 |
| Debt / EBITDA | -6.40 |
| Interest Coverage | -2.68 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -1.50 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -5.54 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.69 |
Delivra Health Brands Inc.'s stock has declined approximately -60% over the past 52 weeks. The 50-day moving average sits at 0.13, while the 200-day moving average is 0.19.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60% |
| 50-Day Moving Average | 0.13 |
| 200-Day Moving Average | 0.19 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Delivra Health Brands Inc. generated 12.60M in revenue and converted that into -134,000.00 in net income, yielding earnings per share of 0.00. EBITDA reached -348,000.00, while operating income came in at -1.65M.
| Revenue | 12.60M |
| Gross Profit | 6.28M |
| Operating Income | -1.65M |
| Pretax Income | -134,000.00 |
| Net Income | -134,000.00 |
| EBITDA | -348,000.00 |
| EBIT | -1.65M |
| Earnings Per Share (EPS) | 0.00 |
Delivra Health Brands Inc. holds 3.49M in cash and equivalents against 2.23M in total debt, resulting in a net debt position of -1.26M. Total book value stands at -22.24M, with working capital of 5.88M providing operational flexibility.
| Cash & Cash Equivalents | 3.49M |
| Total Debt | 2.23M |
| Net Debt | -1.26M |
| Equity (Book Value) | -22.24M |
| Book Value Per Share | -0.72 |
| Working Capital | 5.88M |
Delivra Health Brands Inc. produced -513,000.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -513,000.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -513,000.00 |
| FCF Per Share | -0.02 |
Delivra Health Brands Inc. operates with a gross margin of 49.83, reflecting its pricing power and cost economics. The operating margin of -13.11 and net profit margin of -1.06 provide insight into operational efficiency.
| Gross Margin | 49.83 |
| Operating Margin | -13.11 |
| Pretax Margin | -1.06 |
| Profit Margin | -1.06 |
| EBITDA Margin | -2.76 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.58 |
| FCF Yield | -9.23 |
Delivra Health Brands Inc.'s most recent stock split took place on February 21, 2025 with a 10:1 split ratio.
| Last Split Date | 2/21/2025 |
| Split Ratio | 10:1 |
Delivra Health Brands Inc. posts an Altman Z-Score of -26.23, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -26.23 |